The Food and Drug Administration is predicted to announce approval for mixing and matching COVID-19 booster shots, according to the results of a recent study. This new "mix-and-match" approach set to be announced Wednesday evening follows the findings of a National Institutes of Health study released on Oct. 13. The FDA found that recipients who had received the Johnson & Johnson single-dose vaccine and then received a Moderna vaccine showed an increase in antibody levels, the New York Times reported. Support The Show: https://waynedupree.locals.com See omnystudio.com/listener for privacy information.